🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
This study will treat patients with advanced NSCLC who have already receive...
Status
Completed
Location
Research Site
Start Date
2013-03-04
Trial ID
NCT01802632
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Honor Health Research Institute
Start Date
2019-07-02
Trial ID
NCT03989115
Treatments Being Tested
Osimertinib is a third-generation EGFR (Epidermal growth factor receptor) T...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2021-05-10
Trial ID
NCT04816838
Treatments Being Tested
This is a phase II clinical study evaluating the safety, tolerability, phar...
Status
Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-07-10
Trial ID
NCT07669779
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234
Osimertinib combined with savolitinib in the treatment of EGFR mutated osim...
Status
Recruiting
Location
Qingdao Central Hospital
Start Date
2025-01-01
Trial ID
NCT07322783
Treatments Being Tested
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-04
Trial ID
NCT02197247
This trial is testing two novel combinations (temozolomide plus osimertinib...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-10-29
Trial ID
NCT04541407
Treatments Being Tested
To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Status
Not Yet Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07612137
Treatments Being Tested